Abstract:Background: This study aims to conduct a comparative analysis of the clinical efficacy and safety between pharmacomechanical thrombectomy (PMT) and catheter-directed thrombolysis (CDT) in the context of acute lower-extremity deep venous thrombosis (LEDVT). Methods: A retrospective review of our institution's patient database spanning from February 2011 to December 2019 was performed to identify cases of acute LEDVT. The patients were categorized into 2 distinct groups based on the thrombolytic interventions administered: the PMT group, specifically denoting PMT with AngioJet in our investigation, and the CDT group. Comprehensive data sets encompassing patient demographics, risk factors, procedural specifics, thrombolysis grading, and complications were collected. Subsequent follow-up evaluations at the 2-year mark posttreatment included assessments of postthrombotic syndrome (PTS) and the quality of life. Results: Among the 348 patients identified (mean age: 50.12 ± 15.87 years; 194 females), 200 underwent CDT during the early stage (2011 to 2017), while 148 received PMT between 2017 and 2019. Baseline data between the 2 groups exhibited no statistically significant differences. Thrombus scores significantly decreased in both cohorts posttherapy (each P < 0.001).Patients subjected to PMT demonstrated higher thrombolysis rates (77.35 ± 9.44% vs. 50.85 ± 6.72%), reduced administration of the thrombolytic agent urokinase [20 (20€20) vs. 350 (263€416), P < 0.001], larger limb circumference differences (above the knee: 6.03 ± 1.76 cm vs. 4.51 ± 1.82 cm, P < 0.001; below the knee: 2.90 ± 1.16 cm vs. 2.51 ± 0.90 cm, P < 0.001), and shorter lengths of stay (7.19 ± 3.11 days vs. 12.33 ± 4.77 days, P < 0.001). However, the PMT group exhibited a higher decline in hemoglobin levels (13.41 ± 10.59 g/L vs. 10.88 ± 11.41 g/L, P = 0.038) and an increase in creatinine levels [9.58 (2.32€15.82) umol/L vs. 4.53 (2.87€6.08) umol/L, P < 0.001] compared to the CDT group. No statistically significant differences were observed in the numbers of balloon angioplasty, stent implantation (each P > 0.050), and minor and major complications between the 2 groups. At the 1-year follow-up, PTS occurred in 13.51% of the PMT group compared to 26% of the CDT group (P = 0.025), with a higher incidence of moderate-severe PTS in the CDT group (8% vs. 2.7%, P = 0.036). At the 2-year follow-up, PTS was observed in 16.2% of the PMT group and 31.5% in the CDT group, P = 0.004. Preoperative and postoperative D-values of 36-Item Short Form Health Survey (SF-36) Physical Component Summary and SF-36 Mental Component Summary showed no statistically significant between-group differences. Conclusions: In our institutional experience, both PMT and CDT have proven to be effective and safe therapeutic approaches for managing acute LEDVT. PMT, in particular, demonstrated superior efficacy in achieving thrombosis resolution and mitigating the risk of PTS, affirming its role as a favorable intervention in this clinical context.

Clinical Comparisons of the Acute Lower Extremity Deep Venous Thrombosis Treatment Between Anticoagulation Therapy and Anticoagulation Combined with Thrombolitic Therapy

Outcome Comparisons of Anticoagulation, Systematic Thrombolysis and Catheter-Directed Thrombolysis in the Treatment of Lower Extremity Acute Deep Venous Thrombosis

Comparative Study of Early Therapeutic Effects of Catheter-directed Thrombolysis and Pharmaco Mechanical Thrombolysis for Lower Extremity Deep Vein Thrombosis

[Contrast of curative effect and complications between peripheral venous thrombolysis and catheter-direct thrombolysis for acute deep venous thrombosis in lower limbs].

Clinic Effect Analysis of Compositive Therapy of 126 Cases of Acute Deep Vein Thrombosis of Lower Extremity

Catheter-directed Thrombolysis Compared with Anticoagulation Treatment for Acute Deep Venous Thrombosis-Short and Mid-Term Result

Analysis of Efficacy of Therapy in 165 Cases of Deep Vein Thrombosis of Lower Extremity

Analysis of the Clinical Treatment of Pulmonary Thromboembolism in Two Medical Centers

Application evaluation of different approaches for catheter-directed thrombolysis in acute lower-extremity deep venous thrombosis

The Relationship between Efficacy of Thrombectomy and the Course of Deep Vein Thrombosis of the Lower Extremity

Comparison of Surgical Thrombectomy and Catheter-Directed Thrombolysis for Acute Deep Vein Thrombosis of the Low Extremity Caused by Cockett Syndrome

Comparison of clear effect and the complications, and short and mid-term effects between ultrasound-guided and non-guided catheter-directed thrombolysis in the treatment of deep venous thrombosis of lower extremity

Long-term result of thrombectomy and thrombolysis for acute mixed deep vein thrombosis of the lower extremity

Catheter-directed thrombolysis versus anticoagulant alone for treatment of deep venous thrombosis: a Meta-analysis of randomized trials

Clinical experience of thrombectomy and catheter-directed thrombolysis in the treatment of lower extremity deep vein thrombosis

A Retrospective Study Comparing Pharmacomechanical Thrombectomy with Catheter-Directed Thrombolysis for Acute Deep Venous Thrombosis

The Effect of Anticoagulant Thrombolytic Therapy on Acute Deep Venous Thrombosis Prognosis

Intra-arterial Contimuous Thrombolytic Therapy for Lower Extremity Deep Vein Thrombosis

[Comparison of Surgical Thrombectomy and Interventional Thrombectomy for Acute Deep Vein Thrombosis of the Lower Extremity].

Analysis Thrombolysis with Anticoagulation Treatment for Early Stage of Deep Vein Thrombosis in the Lower Extremities

Mechanical Thrombectomy with AngioJet Compared with Catheter-Directed Thrombolysis for Treatment of Lower Extremity Deep Venous Thrombosis